Regional & Racial Differences in Hemostasis & Risk of Stroke & Heart Disease

区域性

基本信息

项目摘要

DESCRIPTION (provided by applicant): We propose a 5-year research and training program for Dr. Neil A. Zakai (a junior faculty member at the University of Vermont) to develop an independent career in vascular epidemiology by investigating the impact hemostatic biomarker levels have on regional and racial differences in stroke and coronary heart disease (CHD) in the 30,228 black and white individuals in the REasons for Geographic and Racial Differences in Stroke study (REGARDS). Dr. Mary Cushman, an internationally recognized investigator in cardiovascular epidemiology, will serve as the principle mentor for this project. Though the period of this study, Dr. Cushman will support the educational and research aspects of this project. The advisory committee was selected from experts in epidemiology, neurology, and hematology to provide the best opportunities for networking and future collaborations. Dr. Zakai will meet with the advisory committee both in person and through teleconferences on a monthly basis. To achieve a future independent research career for Dr. Zakai, we propose specific coursework in epidemiology and biostatistics at the University of Vermont and the Johns Hopkins Bloomberg School of Public Health. The project will be a case-cohort study focusing on the impact of multiple hemostatic biomarkers (both individually and in groups) on the regional and racial differences in stroke and CHD incidence in the United States. The specific aims will 1) create the nested case-cohort study within REGARDS, 2) use multivariable modeling and factor analysis to elucidate mechanisms for stroke and CHD and 3) integrate hemostatic biomarkers and traditional CVD risk factors into a model for stroke and CHD risk that can account for racial and/or regional differences in CVD. The Laboratory for Clinical and Biochemical Research at the University of Vermont serves as an ideal setting to conduct this research by bringing together the laboratory aspects and the epidemiological expertise to ensure a rich translational research experience.
描述(由申请人提供):我们提出了一个为期5年的研究和培训计划,博士尼尔A。Zakai(佛蒙特大学初级教师)通过在30,228名黑人和白色中调查止血生物标志物水平对中风和冠心病(CHD)的地区和种族差异的影响,在血管流行病学领域发展独立职业生涯中风研究中的地理和种族差异的原因(REGARD)。 玛丽库什曼博士,国际公认的心血管流行病学研究者,将担任本项目的主要导师。在本研究期间,Cushman博士将支持该项目的教育和研究方面。咨询委员会从流行病学、神经病学和血液学专家中选出,为网络和未来合作提供最佳机会。Zakai博士将每月亲自和通过电话会议与咨询委员会会面。Zakai,我们建议在佛蒙特大学和约翰霍普金斯彭博公共卫生学院的流行病学和生物统计学的具体课程。 该项目将是一项病例队列研究,重点关注多种止血生物标志物(单独和成组)对美国卒中和CHD发病率的地区和种族差异的影响。具体目标是:1)在REGARDS中创建嵌套病例队列研究,2)使用多变量建模和因子分析来阐明卒中和CHD的机制,3)将止血生物标志物和传统CVD风险因素整合到卒中和CHD风险模型中,该模型可以解释CVD的种族和/或地区差异。 佛蒙特大学的临床和生化研究实验室是进行这项研究的理想场所,它将实验室方面和流行病学专业知识结合在一起,以确保丰富的转化研究经验。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Neil Adrian Zakai其他文献

Neil Adrian Zakai的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Neil Adrian Zakai', 18)}}的其他基金

Core B: Study Design and Molecular Epidemiology Core
核心 B:研究设计和分子流行病学核心
  • 批准号:
    10447827
  • 财政年份:
    2020
  • 资助金额:
    $ 14.1万
  • 项目类别:
Core B: Study Design and Molecular Epidemiology Core
核心 B:研究设计和分子流行病学核心
  • 批准号:
    10230991
  • 财政年份:
    2020
  • 资助金额:
    $ 14.1万
  • 项目类别:
Core B: Study Design and Molecular Epidemiology Core
核心 B:研究设计和分子流行病学核心
  • 批准号:
    10640146
  • 财政年份:
    2020
  • 资助金额:
    $ 14.1万
  • 项目类别:
Thrombosis and Bleeding Risk Assessment in Medical Inpatients
住院患者的血栓形成和出血风险评估
  • 批准号:
    10394871
  • 财政年份:
    2019
  • 资助金额:
    $ 14.1万
  • 项目类别:
Thrombosis and Bleeding Risk Assessment in Medical Inpatients
住院患者的血栓形成和出血风险评估
  • 批准号:
    9927665
  • 财政年份:
    2019
  • 资助金额:
    $ 14.1万
  • 项目类别:
Regional & Racial Differences in Hemostasis & Risk of Stroke & Heart Disease
区域性
  • 批准号:
    7894120
  • 财政年份:
    2010
  • 资助金额:
    $ 14.1万
  • 项目类别:
Regional & Racial Differences in Hemostasis & Risk of Stroke & Heart Disease
区域性
  • 批准号:
    8238403
  • 财政年份:
    2010
  • 资助金额:
    $ 14.1万
  • 项目类别:
Regional & Racial Differences in Hemostasis & Risk of Stroke & Heart Disease
区域性
  • 批准号:
    8650305
  • 财政年份:
    2010
  • 资助金额:
    $ 14.1万
  • 项目类别:
Regional & Racial Differences in Hemostasis & Risk of Stroke & Heart Disease
区域性
  • 批准号:
    8079650
  • 财政年份:
    2010
  • 资助金额:
    $ 14.1万
  • 项目类别:
Reasons for Racial Disparities in Venous Thromboembolism
静脉血栓栓塞症种族差异的原因
  • 批准号:
    7814160
  • 财政年份:
    2009
  • 资助金额:
    $ 14.1万
  • 项目类别:

相似海外基金

Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 14.1万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mighty Accounting - Accountancy Automation for 1-person limited companies.
Mighty Accounting - 1 人有限公司的会计自动化。
  • 批准号:
    10100360
  • 财政年份:
    2024
  • 资助金额:
    $ 14.1万
  • 项目类别:
    Collaborative R&D
Accounting for the Fall of Silver? Western exchange banking practice, 1870-1910
白银下跌的原因是什么?
  • 批准号:
    24K04974
  • 财政年份:
    2024
  • 资助金额:
    $ 14.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A New Direction in Accounting Education for IT Human Resources
IT人力资源会计教育的新方向
  • 批准号:
    23K01686
  • 财政年份:
    2023
  • 资助金额:
    $ 14.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An empirical and theoretical study of the double-accounting system in 19th-century American and British public utility companies
19世纪美国和英国公用事业公司双重会计制度的实证和理论研究
  • 批准号:
    23K01692
  • 财政年份:
    2023
  • 资助金额:
    $ 14.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An Empirical Analysis of the Value Effect: An Accounting Viewpoint
价值效应的实证分析:会计观点
  • 批准号:
    23K01695
  • 财政年份:
    2023
  • 资助金额:
    $ 14.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Accounting model for improving performance on the health and productivity management
提高健康和生产力管理绩效的会计模型
  • 批准号:
    23K01713
  • 财政年份:
    2023
  • 资助金额:
    $ 14.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
CPS: Medium: Making Every Drop Count: Accounting for Spatiotemporal Variability of Water Needs for Proactive Scheduling of Variable Rate Irrigation Systems
CPS:中:让每一滴水都发挥作用:考虑用水需求的时空变化,主动调度可变速率灌溉系统
  • 批准号:
    2312319
  • 财政年份:
    2023
  • 资助金额:
    $ 14.1万
  • 项目类别:
    Standard Grant
New Role of Not-for-Profit Entities and Their Accounting Standards to Be Unified
非营利实体的新角色及其会计准则将统一
  • 批准号:
    23K01715
  • 财政年份:
    2023
  • 资助金额:
    $ 14.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
通过系统地核算测量误差来改善特定年龄和特定原因的五岁以下死亡率 (ACSU5MR),为低收入国家的儿童生存决策提供信息
  • 批准号:
    10585388
  • 财政年份:
    2023
  • 资助金额:
    $ 14.1万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了